Population monitoring using methods of molecular epidemiology combined with reliable data on exposure is an extremely powerful approach to determine the effect of mutagens on human populations. Although human blood and urine have traditionally been used for biomonitoring, an increase in the use of placental and buccal smear samples should be expected. As 603-607 (1996) 
Introduction
It has been generally known that pollution in eastern Europe greatly exceeded the standards in western Europe and the United States. Subjects in these regions believed that pollution from power plants was responsible for higher mortality, cancer incidence, birth defects, and immune deficiency in their children. There was a similar situation in industrial zones of Poland (1,2), East Germany, and Czechoslovakia (3). In the past, there was not enough experience with biomarkers to evaluate environmental exposure; nevertheless, any results relating to environmental pollution and human health were not usually allowed to be published. Furthermore, methodology for this type of study was not on the contemporary level. With political changes in the fall of 1989, we suggested that these regions could be utilized to study the application of human biomarkers and their usefulness for risk assessment (4) . Using internationally acceptable analytical techniques, substantial differences between original opinion and new scientific data were noticed. Experience from these studies allows us to comment on the use of biomarkers for human biomonitoring.
It is necessary to consider exposure evaluation for the use of any biomarker. The impact of pollutants should be evaluated from all expected sources, usually air, water, and food. If we evaluate the effect of air pollution, not only ambient but also personal exposure should be determined. Many papers on this topic lack concurrent data on air pollution measured in the same period when blood samples were collected (1, 2) . Pollution in eastern Europe changes significantly with changes in economy, which alters demand for electricity; therefore, it is not acceptable to use the results of measurement in one year for the interpretation of biomarkers used several years later.
To characterize a population, we need sufficient information about lifestyle. We should know if the diet contains chemicals that may act as enzyme inducers or mutagens. Modulatory effects of antioxidants have been observed repeatedly (5-8); therefore, plasma levels of vitamins C, A, and E should be determined in order to provide information on the quality of diet and on the supply of antioxidants. The effect of tobacco smoking on various biomarkers has already been proven (9) (10) (11) . The rate of smoking is higher in polluted regions and in lower socioeconomic groups. Determining cotinine levels in urine or other fluids has become the method of choice to check the accuracy of answers in questionnaires for active and passive smoking (12) . Alcohol consumption in higher doses may act as a modulator or, through its metabolism, increase the level of free radicals (13, 14) . Hartmann et al. (15) recently published data on a similar effect from exhaustive physical exercise.
Biomarkers
Biomarkers in molecular epidemiology are usually classified into three groups: biomarkers of exposure, biomarkers of response or effects, and biomarkers of susceptibility.
Biomarkers of Exposure
Biomarkers of exposure include biomarkers of internal dose and biological effective dose. The detection of mutagenic urine using new bacterial strains simultaneously with analysis for genetic polymorphism (11) .l seem to be the methods of choice (16) . In fact, until now, the only method used to evaluate the impact of exposure to polycyclic aromatic hydrocarbons (PAHs) has been the 32P-postlabeling technique, which was used together with ambient air and personal exposure monitoring (12, 17) . White blood cells (WBC) and lymphocytes are the cells of choice for these studies. A promising method for human biomonitoring is the comet assay, which seems to be very sensitive, but it still waits for international validation (18) .
Biomarkers of Response
Biomarkers of response involve the determination of chromosomal and gene mutations. Certainly the most popular approach is to study chromosome aberrations (19) . Their importance is increased by the Nordic study, which demonstrates the relationship between significantly increased frequency of chromosome aberrations and the risk of cancer (20, 21) . On the other hand, chromosome aberrations are unspecific, corresponding to the complex effect of environment, occupation, and lifestyle. Sister chromatid exchanges (SCE) seem to be sensitive, especially to cigarette smoking (9) . New potential may be expected from the determination of high frequency cells, but its significance to environmental pollution is still lacking (22) . Analysis of micronuclei is advocated to determine also the effect of aneugens. It is certainly a useful method to evaluate the impact of radiation exposure, as well as the effect of aging (23) . A new approach, FISH (fluorescent in situ hybridization), can determine stable chromosome exchanges (24, 25) .
The most sensitive gene mutation seems to be the HPRT mutation (26) . Recently, Albertini et al. (26) and Ammenheuser et al. (27) indicated the effect of transplacental transfer from smoking mothers, as well as the effect of social environment, but studies of the relationship between HPRT mutations and measured environmental exposure are still to be done (28 A new method of evaluating DNA repair is the comet assay. Green et al. (8) observed the effect of diet and vitamin C on DNA single-strand breaks. It was divided according to glutathione S-transferase Ml (GSTMI) genotype, individuals with the GSTMI null genotype had a significandy increased DNA adduct level in the polluted district ( Figure 2 ). This result implicates a possibility that sensitivity of subjects may be seen especially with high exposure to mutagens. This is consistent with the data of Hirvonen 
Conclusion
In using molecular methods for human biomonitoring, we should not expect that only one method is sufficient. To cover the spectrum of biomarkers, we can succeed only with efficient cooperation among various specialists (epidemiologists, analytical chemists, biochemists, molecular biologists, cytogeneticists, hygienists, etc.). This task becomes the real ground for international collaboration. We should try to characterize possible highly polluted areas and formulate hypotheses about why such studies should be performed. Such regions could become models to test the validity of molecular methods and their possible interpretation. Fruits from this activity will be used to improve our scientific knowledge and to improve human health.
